We have raised our 2024–2026e clean EPS by c1% on average, following our reduced underlying assumptions but including recently completed M&A. We reiterate our BUY and EUR30 target price. For the Q1 report, we will focus on orders, profitability and the market outlook.
A director at Valmet Oyj sold 36,000 shares at 25.600EUR and the significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
We have raised our 2024–2025e clean EBITA by c2% on average, after an in-line Q4 as well as a reiterated outlook and a solid 2024 guidance. Our 3% clean EPS cuts relate to higher than estimated financial costs. We have raised our target price to EUR30 (28) and reiterate our BUY.
Our 2024–2025e clean EPS is unchanged ahead of the Q4 results, due at 12:00 CET on 7 February, followed by a briefing at 13:00 CET. In the report we will focus on orders, the 2024 market outlook and guidance. We expect Valmet to guide for flat or slightly declining sales and clean EBITA YOY (organically down, but with support from M&A). We have raised our target price to EUR30 (28) and reiterate our BUY.
In the upcoming Q3 results, we plan to focus on orders and market outlook commentary. We have made minor 2023–2025e clean EPS changes but have cut our target price to EUR30 (34). We reiterate our BUY as we see upside potential from the currently depressed share price and valuation.
Our 2023e-tilted order cuts have led us to lower our 2024–2025e sales by c3% on average and clean EPS by c5% on average. We expect sales and clean EPS to decline YOY in 2024e. However, as orders are likely to trough in 2023e and recover in 2024e, we reiterate our BUY but have lowered our target price to EUR34 (36).
Ahead of Valmet’s Q2 results (due 26 July, time tbc), we have lowered our clean EPS by 3% for 2023e, 7% for 2024e, and 5% for 2025e. We reiterate our BUY but have cut our target price to EUR36 (40). The recent share price weakness suggests substantial cuts to consensus.
We have raised our 2023–2025e clean EPS by 6% on average, following strong Q1 orders and earnings. We have increased our target price to EUR40 (36) and reiterate our BUY. In our view, Valmet’s attractive sales and earnings mix as well as continued earnings quality improvements warrant multiples expansion.
At its CMD on 8 March, Valmet maintained its strategy and financial targets, as we expected. It highlighted the greater share of stable businesses and sees continued positive end-market demand. We believe Valmet is well positioned for continued sales growth and profitability expansion with strong financials. We reiterate our BUY and EUR36 target price.
At its CMD on 8 March, we expect Valmet to highlight recent developments (Neles acquisition, increased share of stable businesses, cost actions) and give updates on growth drivers, as well as sales growth and profitability expansion avenues in the future. We believe repeated financial targets and an update on Neles cost synergies could be given too. We reiterate our BUY and EUR36 target price.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.